FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Richard Pollard

Research Profile

Disorders

Living Beings

Chemicals & Drugs

Procedures

Concepts & Ideas

Viral Load

Anatomy

Physiology

Co-author Network

Publications

TOP 3
Byambaa Enkhmaa; Xiao-Dong Li; Richard B Pollard; Wei Zhang; Adnan Abbuthalha; Erdembileg Anuurad; David M Asmuth; William Dotterweich; Lars Berglund
HIV disease activity as a modulator of lipoprotein(a) and allele-specific apolipoprotein(a) levels.
Julia M Shaw; Ma Somsouk; J William Critchfield; Steven G Deeks; Juan Carlos Garcia; Peter W Hunt; Delandy H McConnell; Richard B Pollard; Barbara L Shacklett
Short communication: HIV(+) viremic slow progressors maintain low regulatory T cell numbers in rectal mucosa but exhibit high T cell activation.
Philip M Grant; Sudheesh Kanthikeel; Lauren Komarow; Michael M Lederman; Savita Pahwa; Richard B Pollard; Aaron Richterman; Janet Andersen; David M Asmuth; Sridevi Devaraj; Andrew R Zolopa; Irini Sereti
Elevated interleukin 8 and T-helper 1 and T-helper 17 cytokine levels prior to antiretroviral therapy in participants who developed immune reconstitution inflammatory syndrome during ACTG A5164.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Richard Pollard (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Byambaa Enkhmaa; Xiao-Dong Li; Richard B Pollard; Wei Zhang; Adnan Abbuthalha; Erdembileg Anuurad; David M Asmuth; William Dotterweich; Lars Berglund
HIV disease activity as a modulator of lipoprotein(a) and allele-specific apolipoprotein(a) levels.
Arteriosclerosis, thrombosis, and vascular biology 2013;33(2):387-92.
2013: Julia M Shaw; Ma Somsouk; J William Critchfield; Steven G Deeks; Juan Carlos Garcia; Peter W Hunt; Delandy H McConnell; Richard B Pollard; Barbara L Shacklett
Short communication: HIV(+) viremic slow progressors maintain low regulatory T cell numbers in rectal mucosa but exhibit high T cell activation.
AIDS research and human retroviruses 2013;29(1):172-7.
2012: Philip M Grant; Sudheesh Kanthikeel; Lauren Komarow; Michael M Lederman; Savita Pahwa; Richard B Pollard; Aaron Richterman; Janet Andersen; David M Asmuth; Sridevi Devaraj; Andrew R Zolopa; Irini Sereti
Elevated interleukin 8 and T-helper 1 and T-helper 17 cytokine levels prior to antiretroviral therapy in participants who developed immune reconstitution inflammatory syndrome during ACTG A5164.
The Journal of infectious diseases 2012;206(11):1715-23.
2012: David M Asmuth; Timothy Hayes; Thomas H Knight; Zhong-Min Ma; Surinder Mann; Gregory P Melcher; Christopher J Miller; Paolo Troia-Cancio; Tammy Yotter; Anthony Albanese; Richard B Pollard
Gastrointestinal-associated lymphoid tissue immune reconstitution in a randomized clinical trial of raltegravir versus non-nucleoside reverse transcriptase inhibitor-based regimens.
AIDS (London, England) 2012;26(13):1625-34.
2012: Jonathan J Hubbard; David M Asmuth; Lisa Barrett; Teresa Greenwell-Wild; Richard A Lempicki; Robert L Murphy; Richard B Pollard; Sharon M Wahl; Jun Yang; Shyam Kottilil
Host gene expression changes correlating with anti-HIV-1 effects in human subjects after treatment with peginterferon Alfa-2a.
The Journal of infectious diseases 2012;205(9):1443-7.
2012: Jon E Walker; Mehrdad Abedi; Gerhard Bauer; Rachel X Chen; Jeannine McGee; Catherine Nacey; Jan A Nolta; Richard B Pollard; Joseph S Anderson
Generation of an HIV-1-resistant immune system with CD34(+) hematopoietic stem cells transduced with a triple-combination anti-HIV lentiviral vector.
Journal of virology 2012;86(10):5719-29.
2012: Todd Hulgan; Spyros A Kalams; Deborah G Murdock; Richard B Pollard; Gregory Robbins; David Samuels; Doug Selph; Robert Shafer; Benjamin Grady; David W Haas
T cell activation markers and African mitochondrial DNA haplogroups among non-Hispanic black participants in AIDS clinical trials group study 384.
PloS one 2012;7(8):e43803.
2012: Maura Manion; Kathy Medvik; Robert Murphy; Richard B Pollard; Benigno Rodriguez; Robert T Schooley; Scott F Sieg; David M Asmuth; Edward Barker; Kirsten E Brady; Nick Funderburg; Clifford V Harding; Gareth Hardy; Alan Landay; Michael M Lederman
Interferon-alpha administration enhances CD8+ T cell activation in HIV infection.
PloS one 2012;7(1):e30306.
2011: Benjamin J Grady; David W Haas; Todd Hulgan; Spyros A Kalams; Deborah G Murdock; Richard B Pollard; Marylyn D Ritchie; Gregory K Robbins; David Samuels; Doug Selph; Robert Shafer; Jeffrey A Canter
Mitochondrial genomics and CD4 T-cell count recovery after antiretroviral therapy initiation in AIDS clinical trials group study 384.
Journal of acquired immune deficiency syndromes (1999) 2011;58(4):363-70.
2011: Julia M Shaw; Ma Somsouk; J William Critchfield; Steven G Deeks; Juan Carlos Garcia; Peter W Hunt; Delandy H McConnell; Richard B Pollard; Barbara L Shacklett
Increased frequency of regulatory T cells accompanies increased immune activation in rectal mucosae of HIV-positive noncontrollers.
Journal of virology 2011;85(21):11422-34.
2011: Collin L Ellis; Timothy L Hayes; Thomas H Knight; Chin-Shang Li; Zhong-Min Ma; Archana H Maniar; Surinder K Mann; Christopher J Miller; Heather A Overman; Richard B Pollard; John C Rutledge; Natalia Torok; Paolo V Troia-Cancio; Jian Wu; Tammy Yotter; Anthony Albanese; David M Asmuth
Molecular characterization of stool microbiota in HIV-infected subjects by panbacterial and order-level 16S ribosomal DNA (rDNA) quantification and correlations with immune activation.
Journal of acquired immune deficiency syndromes (1999) 2011;57(5):363-70.
2011: Ronald J Bosch; Lawrence Fox; Alan Landay; Ronald Mitsuyasu; Richard B Pollard; Evgenia Aga
A randomized trial of interleukin-2 during withdrawal of antiretroviral treatment.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2011;31(6):481-3.
2010: April L Ferre; Peter W Hunt; Delandy H McConnell; Megan M Morris; Juan C Garcia; Richard B Pollard; Hal F Yee; Jeffrey N Martin; Steven G Deeks; Barbara L Shacklett
HIV controllers with HLA-DRB1*13 and HLA-DQB1*06 alleles have strong, polyfunctional mucosal CD4+ T-cell responses.
Journal of virology 2010;84(21):11020-9.
2010: April L Ferre; Donna Lemongello; Peter W Hunt; Megan M Morris; Juan Carlos Garcia; Richard B Pollard; Hal F Yee; Jeffrey N Martin; Steven G Deeks; Barbara L Shacklett
Immunodominant HIV-specific CD8+ T-cell responses are common to blood and gastrointestinal mucosa, and Gag-specific responses dominate in rectal mucosa of HIV controllers.
Journal of virology 2010;84(19):10354-65.
2010: Robert T Schooley; John Spritzler; Hongying Wang; Michael M Lederman; Diane V Havlir; Daniel R Kuritzkes; Richard B Pollard; Cathy Battaglia; Michael Robertson; Devan Mehrotra; Danilo Casimiro; Kara Cox; Barbara Schock
AIDS clinical trials group 5197: a placebo-controlled trial of immunization of HIV-1-infected persons with a replication-deficient adenovirus type 5 vaccine expressing the HIV-1 core protein.
The Journal of infectious diseases 2010;202(5):705-16.
2010: Bernard J C Macatangay; Lu Zheng; Charles Rinaldo; Alan L Landay; Richard B Pollard; Savita Pahwa; Michael M Lederman; R Pat Bucy
Comparison of immunologic assays for detecting immune responses in HIV immunotherapeutic studies: AIDS Clinical Trials Group Trial A5181.
Clinical and vaccine immunology : CVI 2010;17(9):1452-9.
2010: Jeffrey Lennox; Edwin Dejesus; Daniel S. Berger; Adriano Lazzarin; Richard B Pollard; Jose Valdez Ramalho Madruga; Jing Zhao; Hong Wan; Christopher L Gilbert; Hedy Teppler; Anthony Rodgers; Richard J O Barnard; Michael D Miller; Mark J DiNubile; Bach-Yen Nguyen; Randi Leavitt; Peter Sklar
Raltegravir versus Efavirenz regimens in treatment-naive HIV-1-infected patients: 96-week efficacy, durability, subgroup, safety, and metabolic analyses.
Journal of acquired immune deficiency syndromes (1999) 2010;55(1):39-48.
2010: Robert Kalayjian; Rhoderick N Machekano; Nesrine Rizk; Gregory K Robbins; Rajesh T Gandhi; Benigno Rodriguez; Richard B Pollard; Michael M Lederman; Alan Landay
Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapy.
The Journal of infectious diseases 2010;201(12):1796-805.
2010: Keith Warren Crawford; John Spritzler; Robert C Kalayjian; Teresa Parsons; Alan Landay; Richard B Pollard; Vicki Stocker; Michael M Lederman; Charles Flexner
Age-related changes in plasma concentrations of the HIV protease inhibitor lopinavir.
AIDS research and human retroviruses 2010;26(6):635-43.
2010: David M Asmuth; Robert L Murphy; Susan L Rosenkranz; Juan J L Lertora; Shyam Kottilil; Yoninah Cramer; Ellen S Chan; Robert T Schooley; Charles Rinaldo; Nathan Thielman; Xiao-Dong Li; Sharon M Wahl; Jessica Shore; Jennifer Janik; Richard A Lempicki; Yaa Simpson; Richard B Pollard
Safety, tolerability, and mechanisms of antiretroviral activity of pegylated interferon Alfa-2a in HIV-1-monoinfected participants: a phase II clinical trial.
The Journal of infectious diseases 2010;201(11):1686-96.
2010: Timothy W Schacker; Ronald J Bosch; Kara Bennett; Richard B Pollard; Gregory K Robbins; Ann C Collier; Roy M Gulick; John Spritzler; Donna Mildvan
Measurement of naive CD4 cells reliably predicts potential for immune reconstitution in HIV.
Journal of acquired immune deficiency syndromes (1999) 2010;54(1):59-62.
2010: Kimberly Smith; Lu Zheng; Ronald Bosch; David M Margolis; Allan Tenorio; Laura Napolitano; Michael Saag; Elizabeth Connick; Barry H Gross; Isaac R Francis; Hernan Valdez; Norma Muurahainen; Vicky Stocker; Richard B Pollard
Treatment with recombinant growth hormone is associated with modest improvement in CD4 lymphocyte reconstitution in HIV-infected persons on antiretroviral therapy: results of ACTG A5174.
AIDS research and human retroviruses 2010;26(4):425-32.
2010: Ronald J Bosch; Richard B Pollard; Alan Landay; Evgenia Aga; Lawrence Fox; Ronald Mitsuyasu
Continuing or adding IL-2 in patients treated with antiretroviral therapy (ACTG Protocol A5051, a rollover trial of ACTG Protocol A328).
AIDS research and therapy 2010;7():30.
2009: Tsuyoshi Yoshida; Makiko Kobayashi; Xiao-Dong Li; Richard B Pollard; Fujio Suzuki
Inhibitory effect of glycyrrhizin on the neutrophil-dependent increase of R5 HIV replication in cultures of macrophages.
Immunology and cell biology 2009;87(7):554-8.
2009: Jeffrey Lennox; Edwin DeJesus; Adriano Lazzarin; Richard B Pollard; Jose Valdez Ramalho Madruga; Daniel S. Berger; Jing Zhao; Xia Xu; Angela Williams-Diaz; Anthony Rodgers; Richard J O Barnard; Michael D Miller; Mark J DiNubile; Bach-Yen Nguyen; Randi Leavitt; Peter Sklar
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial.
Lancet 2009;374(9692):796-806.
2009: Samir K Gupta; Lauren Komarow; Roy M Gulick; Richard B Pollard; Gregory Robbins; Nora Franceschini; Lynda A Szczech; Susan L Koletar; Robert C Kalayjian
Proteinuria, creatinine clearance, and immune activation in antiretroviral-naive HIV-infected subjects.
The Journal of infectious diseases 2009;200(4):614-8.
2009: Angela Meier; J Judy Chang; Ellen S Chan; Richard B Pollard; Harlyn K Sidhu; Smita Kulkarni; Tom Fang Wen; Robert J Lindsay; Liliana Orellana; Donna Mildvan; Suzane Bazner; Hendrik Streeck; Galit Alter; Jeffrey D Lifson; Mary Carrington; Ronald J Bosch; Gregory Robbins; Marcus Altfeld
Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1.
Nature medicine 2009;15(8):955-9.
2009: April L Ferre; Peter W Hunt; J William Critchfield; Delandy H Young; Megan M Morris; Juan C Garcia; Richard B Pollard; Hal F Yee; Jeffrey N Martin; Steven G Deeks; Barbara L Shacklett
Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control.
Blood 2009;113(17):3978-89.
2009: Jack T Stapleton; Kathryn Chaloner; Jingyang Zhang; Donna Klinzman; Inara Espinelli L Souza; Jinhua Xiang; Alan Landay; John Fahey; Richard B Pollard; Ronald Mitsuyasu
GBV-C viremia is associated with reduced CD4 expansion in HIV-infected people receiving HAART and interleukin-2 therapy.
AIDS (London, England) 2009;23(5):605-10.
2009: Gail Skowron; John G Spritzler; Jodi Weidler; Gregory Robbins; Victoria A Johnson; Ellen S Chan; David M Asmuth; Rajesh T Gandhi; Yolanda Lie; Michael Bates; Richard B Pollard
Replication capacity in relation to immunologic and virologic outcomes in HIV-1-infected treatment-naive subjects.
Journal of acquired immune deficiency syndromes (1999) 2009;50(3):250-8.
2009: Allan Tenorio; John Spritzler; Jeffrey Martinson; Caroline N Gichinga; Richard B Pollard; Michael M Lederman; Robert C Kalayjian; Alan L Landay
The effect of aging on T-regulatory cell frequency in HIV infection.
Clinical immunology (Orlando, Fla.) 2009;130(3):298-303.
2009: Gregory Robbins; John G Spritzler; Ellen S Chan; David M Asmuth; Rajesh T Gandhi; Benigno Rodriguez; Gail Skowron; Paul R Skolnik; Robert W Shafer; Richard B Pollard
Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;48(3):350-61.
2008: Adriana Weinberg; J Spritzler; M Nokta; R Schrier; A Landay; D Brown; Richard B Pollard
In vitro cell-mediated immune responses of human immunodeficiency virus-infected and -uninfected individuals to whole cytomegalovirus antigens and their subunits.
Clinical and vaccine immunology : CVI 2008;15(9):1398-409.
2008: Go Vera; Richard B Pollard
A cytomegalovirus vaccine for transplantation: are we closer?
The Journal of infectious diseases 2008;197(12):1631-3.
2008: Richard Davey; Peter E Pertel; Alice Benson; Delanie J Cassell; Brian G Gazzard; Mark Holodniy; Jacob P Lalezari; Yves Levy; Ronald T Mitsuyasu; Frank J Palella; Richard B Pollard; Prabhu Rajagopalan; Michael S Saag; Robert A Salata; Beverly E Sha; Shurjeel Choudhri
Safety, tolerability, pharmacokinetics, and efficacy of an interleukin-2 agonist among HIV-infected patients receiving highly active antiretroviral therapy.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2008;28(2):89-100.
2008: David M Asmuth; Kristina Abel; Michael D George; Satya Dandekar; Richard B Pollard; Christopher J Miller
Pegylated interferon-alpha 2a treatment of chronic SIV-infected macaques.
Journal of medical primatology 2008;37(1):26-30.
2008: J William Critchfield; Delandy H Young; Timothy L Hayes; Jerome V Braun; Juan C Garcia; Richard B Pollard; Barbara L Shacklett
Magnitude and complexity of rectal mucosa HIV-1-specific CD8+ T-cell responses during chronic infection reflect clinical status.
PloS one 2008;3(10):e3577.
2007: J William Critchfield; Donna Lemongello; Digna H Walker; Juan C Garcia; David M Asmuth; Richard B Pollard; Barbara L Shacklett
Multifunctional human immunodeficiency virus (HIV) gag-specific CD8+ T-cell responses in rectal mucosa and peripheral blood mononuclear cells during chronic HIV type 1 infection.
Journal of virology 2007;81(11):5460-71.
2007: Tsuyoshi Yoshida; Vickie C Jones; Makiko Kobayashi; Xiao-Dong Li; Richard B Pollard; Fujio Suzuki
Acceleration of R5 HIV replication by polymorphonuclear neutrophils in cultures of macrophages.
Immunology and cell biology 2007;85(3):215-9.
2007: Ronald T Mitsuyasu; Rebecca Gelman; Deborah Weng Cherng; Alan Landay; John Fahey; Richard Reichman; Alejo Erice; R Pat Bucy; J. Michael Kilby; Michael M Lederman; Carol D Hamilton; Juan Lertora; Becky L White; Pablo Tebas; Anne-Marie Duliege; Richard B Pollard
The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328.
Archives of internal medicine 2007;167(6):597-605.
2006: Michael M Lederman; Laura M Smeaton; Kimberly Y Smith; Benigno Rodriguez; Minya Pu; Hongying Wang; Anne Sevin; Pablo Tebas; Scott F Sieg; Kathy Medvik; David M Margolis; Richard B Pollard; Hildegund C J Ertl; Hernan Valdez
Cyclosporin A provides no sustained immunologic benefit to persons with chronic HIV-1 infection starting suppressive antiretroviral therapy: results of a randomized, controlled trial of the AIDS Clinical Trials Group A5138.
The Journal of infectious diseases 2006;194(12):1677-85.
2006: J. Michael Kilby; R Pat Bucy; Donna Mildvan; Margaret A Fischl; Jorge Santana-Bagur; Jeffrey Lennox; Christopher D Pilcher; Andrew R Zolopa; Jody Lawrence; Richard B Pollard; Raphaelle El Habib; David Sahner; Lawrence Fox; Evgenia Aga; Ronald J Bosch; Ronald T Mitsuyasu
A randomized, partially blinded phase 2 trial of antiretroviral therapy, HIV-specific immunizations, and interleukin-2 cycles to promote efficient control of viral replication (ACTG A5024).
The Journal of infectious diseases 2006;194(12):1672-6.
2006: Marion G Peters; Janet Andersen; Patrick Lynch; Tun Liu; Beverly Alston-Smith; Carol L Brosgart; Jeffrey M Jacobson; Victoria A Johnson; Richard B Pollard; James F Rooney; Kenneth E Sherman; Susan Swindells; Bruce Polsky
Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127.
Hepatology (Baltimore, Md.) 2006;44(5):1110-6.
2006: Alison A Motsinger; Marylyn Ritchie; Robert W Shafer; Gregory Robbins; Gene D Morse; Line Labbe; Grant R Wilkinson; David B Clifford; Richard T D'Aquila; Victoria A Johnson; Richard B Pollard; Thomas C Merigan; Martin S Hirsch; John P Donahue; Richard B Kim; David W Haas
Multilocus genetic interactions and response to efavirenz-containing regimens: an adult AIDS clinical trials group study.
Pharmacogenetics and genomics 2006;16(11):837-45.
2006: Miwa Takei; Makiko Kobayashi; David N Herndon; Richard B Pollard; Fujio Suzuki
Glycyrrhizin inhibits the manifestations of anti-inflammatory responses that appear in association with systemic inflammatory response syndrome (SIRS)-like reactions.
Cytokine 2006;35(5-6):295-301.
2006: Rajesh T Gandhi; John Spritzler; Ellen Chan; David M Asmuth; Benigno Rodriguez; Thomas C Merigan; Martin S Hirsch; Robert W Shafer; Gregory Robbins; Richard B Pollard
Effect of baseline- and treatment-related factors on immunologic recovery after initiation of antiretroviral therapy in HIV-1-positive subjects: results from ACTG 384.
Journal of acquired immune deficiency syndromes (1999) 2006;42(4):426-34.
2006: Tsuyoshi Yoshida; Yasuhiro Tsuda; Dan Takeuchi; Makiko Kobayashi; Richard B Pollard; Fujio Suzuki
Glycyrrhizin inhibits neutrophil-associated generation of alternatively activated macrophages.
Cytokine 2006;33(6):317-22.
2006: Michael Borucki; Mark Holodniy; Gerald Pierone; Peter Ruane; Corklin R Steinhart; Sally Williams; Trevor Slom; Frank J Palella; C Bradley Hare; Yasuhisa Yoshidao; Xiao-Dong Li; Richard B Pollard
The safety and tolerability of Z-100 in patients infected with HIV-1.
Antiviral therapy 2006;11(3):297-303.
2005: David W Haas; Laura M Smeaton; Robert W Shafer; Gregory Robbins; Gene D Morse; Line Labbe; Grant R Wilkinson; David B Clifford; Richard T D'Aquila; Victor De Gruttola; Richard B Pollard; Thomas C Merigan; Martin S Hirsch; Alfred L George; John P Donahue; Richard B Kim
Pharmacogenetics of long-term responses to antiretroviral regimens containing Efavirenz and/or Nelfinavir: an Adult Aids Clinical Trials Group Study.
The Journal of infectious diseases 2005;192(11):1931-42.
2005: Haydar Kuekrek; Tobias Schlingmann; Hernan Valdez; Bernhard O Boehm; Richard B Pollard; Ronald T Mitsuyasu; Frank-Detlef Goebel; Michael M Lederman; Paul V Lehmann; Magdalena Tary-Lehmann
Differential effect of interleukin-2 treatment on primary and secondary immunizations in HIV infected individuals.
AIDS (London, England) 2005;19(17):1967-74.
2005: Robert Kalayjian; John Spritzler; Minya Pu; Alan Landay; Richard B Pollard; Vicki Stocker; Lena-Al Harthi; Barry H Gross; Isaac R Francis; Susan A Fiscus; Pablo Tebas; Ronald J Bosch; Victor Valcour; Michael M Lederman
Distinct mechanisms of T cell reconstitution can be identified by estimating thymic volume in adult HIV-1 disease.
The Journal of infectious diseases 2005;192(9):1577-87.
2005: Franco Lori; Andrea Foli; Antonella Groff; Luca Lova; Lucia Whitman; Nyasha Bakare; Richard B Pollard; Julianna Lisziewicz
Optimal suppression of HIV replication by low-dose hydroxyurea through the combination of antiviral and cytostatic ('virostatic') mechanisms.
AIDS (London, England) 2005;19(11):1173-81.
2005: David M Asmuth; Nan Wang; Ying Lu; Xiao-Dong Li; Lisa M Reece; Nicholas H A Terry; Richard B Pollard; Mostafa Nokta; James Leary; R Allen White
Cell cycle kinetic dysregulation in HIV-infected normal lymphocytes.
Cytometry. Part A : the journal of the International Society for Analytical Cytology 2005;66(1):41-51.
2005: R Allen White; David M Asmuth; Ying Lu; Nan Wang; Xiao-Dong Li; Lisa M Reece; Richard B Pollard; Mostafa Nokta; James Leary; Nicholas H A Terry
Estimating cell death in G(2)M using bivariate BrdUrd/DNA flow cytometry.
Cytometry. Part A : the journal of the International Society for Analytical Cytology 2005;66(1):32-40.
2005: Franco Lori; Richard B Pollard; Lucia Whitman; Nyasha Bakare; G Blick; P Shalit; Andrea Foli; D Peterson; A Tennenberg; S Schrader; B Rashbaum; C Farthing; D Herman; D Norris; P Greiger; I Frank; Antonella Groff; Luca Lova; David M Asmuth; Julianna Lisziewicz
Lowering the dose of hydroxyurea minimizes toxicity and maximizes anti-HIV potency.
AIDS research and human retroviruses 2005;21(4):263-72.
2005: Miwa Takei; Makiko Kobayashi; Xiao-Dong Li; Richard B Pollard; Fujio Suzuki
Glycyrrhizin inhibits R5 HIV replication in peripheral blood monocytes treated with 1-methyladenosine.
Pathobiology : journal of immunopathology, molecular and cellular biology 2005;72(3):117-23.
2005: Patrick F Smith; Robert DiCenzo; Alan Forrest; Mark J Shelton; Gerald Friedland; Michael F Para; Richard B Pollard; Margaret A Fischl; Robin DiFrancesco; Gene D Morse
Population pharmacokinetics of delavirdine and N-delavirdine in HIV-infected individuals.
Clinical pharmacokinetics 2005;44(1):99-109.
2004: Michael J Borucki; John Spritzler; David M Asmuth; John W Gnann; Martin S Hirsch; Mostafa Nokta; Francesca T Aweeka; Paul I Nadler; Fred R Sattler; Beverly Alston; Thomas T Nevin; Susan Owens; Karen Waterman; Larry Hubbard; Angela Caliendo; Richard B Pollard
A phase II, double-masked, randomized, placebo-controlled evaluation of a human monoclonal anti-Cytomegalovirus antibody (MSL-109) in combination with standard therapy versus standard therapy alone in the treatment of AIDS patients with Cytomegalovirus retinitis.
Antiviral research 2004;64(2):103-11.
2004: David M Asmuth; Hien H Nguyen; Gregory P Melcher; Stuart H Cohen; Richard B Pollard
Treatments for hepatitis B.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(9):1353-62.
2004: Craig W Hendrix; Ann C Collier; Michael M Lederman; Dominique Schols; Richard B Pollard; Stephen Brown; J Brooks Jackson; Robert W Coombs; Marshall J Glesby; Charles Flexner; Gary J Bridger; Karin Badel; Ronald T MacFarland; Geoffrey Henson; Gary Calandra
Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection.
Journal of acquired immune deficiency syndromes (1999) 2004;37(2):1253-62.
2004: Beverly E Sha; Michelle Onorato; John A Bartlett; Ronald J Bosch; Evgenia Aga; Mostafa Nokta; Elizabeth M Adams; Xiao-Dong Li; John Eldridge; Richard B Pollard
Safety and immunogenicity of a polyvalent peptide C4-V3 HIV vaccine in conjunction with IL-12.
AIDS (London, England) 2004;18(8):1203-6.
2004: Mary A Vogler; Hedy Teppler; Rebecca Gelman; Fred Valentine; Michael M Lederman; Roger J Pomerantz; Richard B Pollard; Deborah Weng Cherng; Charles J Gonzalez; Kathleen E Squires; Ian Frank; Donna Mildvan; Laura F Mahon; Barbara Schock
Daily low-dose subcutaneous interleukin-2 added to single- or dual-nucleoside therapy in HIV infection does not protect against CD4+ T-cell decline or improve other indices of immune function: results of a randomized controlled clinical trial (ACTG 248).
Journal of acquired immune deficiency syndromes (1999) 2004;36(1):576-87.
2004: Mark A Jacobson; Holden T Maecker; Patricia L Orr; Ron D'Amico; Mark L Van Natta; Xiao-Dong Li; Richard B Pollard; Barry M Bredt
Results of a cytomegalovirus (CMV)-specific CD8+/interferon- gamma+ cytokine flow cytometry assay correlate with clinical evidence of protective immunity in patients with AIDS with CMV retinitis.
The Journal of infectious diseases 2004;189(8):1362-73.
2004: Robin Wood; Keikawus Arastéh; Hans-Jürgen Stellbrink; Eugenio Teofilo; François Raffi; Richard B Pollard; Joseph J Eron; Jane Yeo; Judith Millard; Mary Beth Wire; Odin J Naderer
Six-week randomized controlled trial to compare the tolerabilities, pharmacokinetics, and antiviral activities of GW433908 and amprenavir in human immunodeficiency virus type 1-infected patients.
Antimicrobial agents and chemotherapy 2004;48(1):116-23.
2003: Gregory Robbins; Victor De Gruttola; Robert W Shafer; Laura M Smeaton; Snyder Sally; Carla Pettinelli; Michael P Dubé; Margaret A Fischl; Richard B Pollard; Robert Delapenha; Linda Gedeon; Charles van der Horst; Robert L Murphy; Mark I Becker; Richard T D'Aquila; STEFANO VELLA; Thomas C Merigan; Martin S Hirsch
Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection.
The New England journal of medicine 2003;349(24):2293-303.
2003: Robert Kalayjian; Alan Landay; Richard B Pollard; Dennis D Taub; Barry H Gross; Isaac R Francis; Anne Sevin; Minya Pu; John Spritzler; Miriam Chernoff; Ann Namkung; Lawrence Fox; Ana Martinez; Karen Waterman; Susan A Fiscus; Beverly E Sha; Debra Johnson; Stanley Slater; Franck Rousseau; Michael M Lederman
Age-related immune dysfunction in health and in human immunodeficiency virus (HIV) disease: association of age and HIV infection with naive CD8+ cell depletion, reduced expression of CD28 on CD8+ cells, and reduced thymic volumes.
The Journal of infectious diseases 2003;187(12):1924-33.
2003: Jeffrey P Nadler; Joseph C Gathe; Richard B Pollard; Gary J Richmond; Qiming Liao; Sandy Griffith; Charles Tracey Lancaster; Jaime E Hernandez; Keith A Pappa
Twice-daily amprenavir 1200 mg versus amprenavir 600 mg/ritonavir 100 mg, in combination with at least 2 other antiretroviral drugs, in HIV-1-infected patients.
BMC infectious diseases 2003;3():10.
2003: Hiroyuki Kobayashi; Makiko Kobayashi; Hitoshi Takahashi; David N Herndon; Richard B Pollard; Fujio Suzuki
Soluble IL-4 receptor improves the skin-graft-associated cytomegalovirus infection in thermally injured mice.
Burns : journal of the International Society for Burn Injuries 2003;29(4):315-21.
2003: R Rossero; David M Asmuth; James J Grady; David McKinsey; S Green; L Andron; Richard B Pollard
Hydroxyurea in combination with didanosine and stavudine in antiretroviral-experienced HIV-infected subjects with a review of the literature.
International journal of STD & AIDS 2003;14(5):350-5.
2003: Makiko Kobayashi; Hitoshi Takahashi; David N Herndon; Richard B Pollard; Fujio Suzuki
Therapeutic effects of IL-12 combined with benzoylmesaconine, a non-toxic aconitine-hydrolysate, against herpes simplex virus type 1 infection in mice following thermal injury.
Burns : journal of the International Society for Burn Injuries 2003;29(1):37-42.
2003: Hernan Valdez; Ronald T Mitsuyasu; Alan Landay; Anne Sevin; Ellen S Chan; John Spritzler; Spyros A Kalams; Richard B Pollard; John Fahey; Lawrence Fox; Ann Namkung; Scharla Estep; Ronald Moss; David Sahner; Michael M Lederman
Interleukin-2 Increases CD4+ lymphocyte numbers but does not enhance responses to immunization: results of A5046s.
The Journal of infectious diseases 2003;187(2):320-5.
2002: Tatsushi Katakura; Makiko Kobayashi; Kazuhiko Fujita; David N Herndon; Richard B Pollard; Fujio Suzuki
A combination therapy using IL-12 and soluble IL-4 receptor on herpes simplex virus Type 1 infection in a human-SCID chimera model of thermal injury.
Clinical immunology (Orlando, Fla.) 2002;105(3):363-70.
2002: Hitoshi Takahashi; Tsuguhiko Tashiro; Masaru Miyazaki; Makiko Kobayashi; Richard B Pollard; Fujio Suzuki
An essential role of macrophage inflammatory protein 1alpha/CCL3 on the expression of host's innate immunities against infectious complications.
Journal of leukocyte biology 2002;72(6):1190-7.
2002: Mostafa Nokta; Xiao-Dong Li; Lena Al-Harthi; Joan Nichols; Anna M Pou; David M Asmuth; Alan Landay; Richard B Pollard
Entrapment of recent thymic emigrants in lymphoid tissues from HIV-infected patients: association with HIV cellular viral load.
AIDS (London, England) 2002;16(16):2119-27.
2002: Makiko Kobayashi; Kazuhiko Fujita; Tatsushi Katakura; Tokuichiro Utsunomiya; Richard B Pollard; Fujio Suzuki
Inhibitory effect of glycyrrhizin on experimental pulmonary metastasis in mice inoculated with B16 melanoma.
Anticancer research 2002;22(6C):4053-8.
2002: Richard B Pollard
Can HIV infection be treated successfully with a once-daily regimen?
The AIDS reader 2002;12(11):489-90, 494-8, 500, 508.
2002: Makiko Kobayashi; Hitoshi Takahashi; Arthur P Sanford; David N Herndon; Richard B Pollard; Fujio Suzuki
An increase in the susceptibility of burned patients to infectious complications due to impaired production of macrophage inflammatory protein 1 alpha.
Journal of immunology (Baltimore, Md. : 1950) 2002;169(8):4460-6.
2002: Makiko Kobayashi; Hitoshi Takahashi; David N Herndon; Richard B Pollard; Fujio Suzuki
Effect of a combination therapy between IL-12 and soluble IL-4 receptor (sIL-4R) on Candida albicans and herpes simplex virus type I infections in thermally injured mice.
Canadian journal of microbiology 2002;48(10):886-94.
2002: Richard B Pollard; Camlin Tierney; Diane V Havlir; Pablo Tebas; Lawrence Fox; Laura M Smeaton; Douglas Richman; Gerald H Friedland
A phase II randomized study of the virologic and immunologic effect of zidovudine + stavudine versus stavudine alone and zidovudine + lamivudine in patients with >300 CD4 cells who were antiretroviral naive (ACTG 298).
AIDS research and human retroviruses 2002;18(10):699-704.
2002: Katsunori Furukawa; Makiko Kobayashi; David N Herndon; Richard B Pollard; Fujio Suzuki
Appearance of monocyte chemoattractant protein 1 (MCP-1) early after thermal injury: role in the subsequent development of burn-associated type 2 T-cell responses.
Annals of surgery 2002;236(1):112-9.
2002: Katsunori Furukawa; Makiko Kobayashi; Hidetaka Sasaki; David N Herndon; Richard B Pollard; Fujio Suzuki
Cryptococcal encephalitis in thermally injured mice is accelerated by type 2 T-cell responses.
Critical care medicine 2002;30(7):1419-24.
2002: Mostafa Nokta; Fiona Holland; Victor De Gruttola; Vincent C Emery; Mark A Jacobson; Paul Griffiths; Richard B Pollard; Judith E Feinberg
Cytomegalovirus (CMV) polymerase chain reaction profiles in individuals with advanced human immunodeficiency virus infection: relationship to CMV disease.
The Journal of infectious diseases 2002;185(12):1717-22.
2002: Beverly E Sha; Hernan Valdez; Rebecca Gelman; Alan L Landay; Jan Agosti; Ronald T Mitsuyasu; Richard B Pollard; Donna Mildvan; Ann Namkung; Debra M Ogata-Arakaki; Lawrence Fox; Scharla Estep; Alejo Erice; Patrick D Kilgo; Robert E Walker; Lynne Bancroft; Michael M Lederman
Effect of etanercept (Enbrel) on interleukin 6, tumor necrosis factor alpha, and markers of immune activation in HIV-infected subjects receiving interleukin 2.
AIDS research and human retroviruses 2002;18(9):661-5.
2002: Mark A Jacobson; John Spritzler; Alan Landay; Ellen Chan; David Katzenstein; Barbara Schock; Lawrence Fox; JoanaD'arc Roe; Smriti Kundu; Richard B Pollard
A Phase I, placebo-controlled trial of multi-dose recombinant human interleukin-12 in patients with HIV infection.
AIDS (London, England) 2002;16(8):1147-54.
2002: Hidetaka Sasaki; Miwa Takei; Makiko Kobayashi; Richard B Pollard; Fujio Suzuki
Effect of glycyrrhizin, an active component of licorice roots, on HIV replication in cultures of peripheral blood mononuclear cells from HIV-seropositive patients.
Pathobiology : journal of immunopathology, molecular and cellular biology 2002;70(4):229-36.
2001: Hiroyuki Kobayashi; Makiko Kobayashi; David N Herndon; Richard B Pollard; Fujio Suzuki
Susceptibility of thermally injured mice to cytomegalovirus infection.
Burns : journal of the International Society for Burn Injuries 2001;27(7):675-80.
2001: S Kundu-Raychaudhuri; Anne Sevin; Patrick D Kilgo; Mostafa Nokta; Richard B Pollard; T C Merigan
Effect of therapeutic immunization with HIV type 1 recombinant glycoprotein 160 ImmunoAG vaccine in HIV-infected individuals with CD4+ T cell counts of >or=500 and 200-400/mm3 (AIDS Clinical Trials Group Study 246/946).
AIDS research and human retroviruses 2001;17(15):1371-8.
2001: H Nakajima; Makiko Kobayashi; Richard B Pollard; Fujio Suzuki
Monocyte chemoattractant protein-1 enhances HSV-induced encephalomyelitis by stimulating Th2 responses.
Journal of leukocyte biology 2001;70(3):374-80.
2001: F Raffi; V Reliquet; D Podzamczer; Richard B Pollard
Efficacy of nevirapine-based HAART in HIV-1-infected, treatment-naive persons with high and low baseline viral loads.
HIV clinical trials 2001;2(4):317-22.
2001: Mostafa Nokta; Xiao-Dong Li; Joan Nichols; Anna M Pou; David M Asmuth; Richard B Pollard
Homeostasis of naive and memory T cell subpopulations in peripheral blood and lymphoid tissues in the context of human immunodeficiency virus infection.
The Journal of infectious diseases 2001;183(9):1336-42.
2001: Tokuichiro Utsunomiya; Makiko Kobayashi; M Ito; David N Herndon; Richard B Pollard; Fujio Suzuki
Glycyrrhizin restores the impaired IL-12 production in thermally injured mice.
Cytokine 2001;14(1):49-55.
2001: Michael F Para; Leslie A Kalish; Ann C Collier; Richard B Pollard; PN Kumar; L Mintz; FR Wallach; W Lawrence Drew
Qualitative and quantitative PCR measures of cytomegalovirus in patients with advanced HIV infection who require transfusions.
Journal of acquired immune deficiency syndromes (1999) 2001;26(4):320-5.
2001: T Utsunomiya; M Kobayashi; David N Herndon; Richard B Pollard; F Suzuki
A mechanism of interleukin-12 unresponsiveness associated with thermal injury.
The Journal of surgical research 2001;96(2):211-7.
2001: Mostafa Nokta; Xiao-Dong Li; Joan Nichols; M Mallen; Anna M Pou; David M Asmuth; Richard B Pollard
Chemokine/CD4 receptor density ratios correlate with HIV replication in lymph node and peripheral blood of HIV-infected individuals.
AIDS (London, England) 2001;15(2):161-9.
2001: Hidetaka Sasaki; Makiko Kobayashi; Richard B Pollard; Fujio Suzuki
Effects of Z-100, a Mycobacterium-tuberculosis-derived arabinomannan, on the LP-BM5 murine leukemia virus infection in mice.
Pathobiology : journal of immunopathology, molecular and cellular biology 2001;69(2):96-103.
2000: Richard B Pollard
Didanosine once daily: potential for expanded use.
AIDS (London, England) 2000;14(16):2421-8.
2000: H Nakajima; Makiko Kobayashi; Richard B Pollard; Fujio Suzuki
A pathogenic role of Th2 responses on the severity of encephalomyelitis induced in mice by herpes simplex virus type 2 infection.
Journal of neuroimmunology 2000;110(1-2):106-13.
2000: Katsunori Furukawa; Hidetaka Sasaki; Richard B Pollard; Fujio Suzuki
Lanoconazole, a new imidazole antimycotic compound, protects MAIDS mice against encephalitis caused by Cryptococcus neoformans.
The Journal of antimicrobial chemotherapy 2000;46(3):443-50.
2000: M Kaji; Makiko Kobayashi; Richard B Pollard; Fujio Suzuki
Influence of type 2 T cell responses on the severity of encephalitis associated with influenza virus infection.
Journal of leukocyte biology 2000;68(2):180-6.
2000: Diane V Havlir; Camlin Tierney; G H Friedland; Richard B Pollard; Laura M Smeaton; JP Sommadossi; L Fox; H Kessler; K H Fife; Douglas D Richman
In vivo antagonism with zidovudine plus stavudine combination therapy.
The Journal of infectious diseases 2000;182(1):321-5.
2000: Mostafa Nokta; P Turk; Kim Loesch; Richard B Pollard
Neutralization profiles of sera from human immunodeficiency virus (HIV)-infected individuals: relationship to HIV viral load and CD4 cell count.
Clinical and diagnostic laboratory immunology 2000;7(3):412-6.
2000: Tokuichiro Utsunomiya; Makiko Kobayashi; M Ito; Richard B Pollard; Fujio Suzuki
Glycyrrhizin improves the resistance of MAIDS mice to opportunistic infection of Candida albicans through the modulation of MAIDS-associated type 2 T cell responses.
Clinical immunology (Orlando, Fla.) 2000;95(2):145-55.
1999: Richard B Pollard
Analogy of human immunodeficiency virus to hepatitis C virus: the human immunodeficiency model.
The American journal of medicine 1999;107(6B):41S-44S.
1999: Richard B Pollard; D Peterson; D Hardy; J Pottage; Robert L Murphy; Joseph C Gathe; G Beall; V Rutkievicz; L Reynolds; A P Cross; LM Dunkle
Safety and antiretroviral effects of combined didanosine and stavudine therapy in HIV-infected individuals with CD4 counts of 200 to 500 cells/mm3.
Journal of acquired immune deficiency syndromes (1999) 1999;22(1):39-48.
1999: H Kobayashi; M Kobayashi; Thomas A Heming; Akhil Bidani; Richard B Pollard; F Suzuki
Cytokine production by rabbit alveolar macrophages: differences between activated and suppressor cell phenotypes.
Immunology letters 1999;69(3):339-46.
1999: H Kobayashi; Makiko Kobayashi; R L McCauley; David N Herndon; Richard B Pollard; Fujio Suzuki
Cadaveric skin allograft-associated cytomegalovirus transmission in a mouse model of thermal injury.
Clinical immunology (Orlando, Fla.) 1999;92(2):181-7.
1999: Gerald Friedland; Richard B Pollard; B Griffith; M Hughes; Gene D Morse; Roland Bassett; William Freimuth; Lisa M Demeter; E Connick; T Nevin; M Hirsch; Margaret A Fischl
Efficacy and safety of delavirdine mesylate with zidovudine and didanosine compared with two-drug combinations of these agents in persons with HIV disease with CD4 counts of 100 to 500 cells/mm3 (ACTG 261). ACTG 261 Team.
Journal of acquired immune deficiency syndromes (1999) 1999;21(4):281-92.
1999: J E Mobley; Richard B Pollard; S Schrader; M H Adler; T Kelleher; C McLaren
Virological and immunological responses to once-daily dosing of didanosine in combination with stavudine. AI454-143 Team.
AIDS (London, England) 1999;13(11):F87-93.
1999: Hiroyuki Kobayashi; Makiko Kobayashi; T Utsunomiya; David N Herndon; Richard B Pollard; Fujio Suzuki
Therapeutic protective effects of IL-12 combined with soluble IL-4 receptor against established infections of herpes simplex virus type 1 in thermally injured mice.
Journal of immunology (Baltimore, Md. : 1950) 1999;162(12):7148-54.
1999: N Nakajima; T Utsunomiya; M Kobayashi; Richard B Pollard; F Suzuki
[Biological properties of T6S cells, a clone of burn-associated type 2 T cells].
Nihon Rinshō Men'eki Gakkai kaishi = Japanese journal of clinical immunology 1999;22(3):123-30.
1999: Tokuichiro Utsunomiya; Makiko Kobayashi; David N Herndon; Richard B Pollard; Fujio Suzuki
Effects of glycyrrhizin, an active component of licorice roots, on Candida albicans infection in thermally injured mice.
Clinical and experimental immunology 1999;116(2):291-8.
1999: Mostafa Nokta; R Rossero; Joan Nichols; M Rosenbaum; Richard B Pollard
Effect of didanosine, stavudine, and hydroxyurea therapy on apoptosis in CD45RA+ and CD45RO+ T lymphocyte subpopulations.
AIDS research and human retroviruses 1999;15(3):255-64.
1999: Makiko Kobayashi; S M Davis; Tokuichiro Utsunomiya; Richard B Pollard; Fujio Suzuki
Antiviral effect of gingyo-san, a traditional Chinese herbal medicine, on influenza A2 virus infection in mice.
The American journal of Chinese medicine 1999;27(1):53-62.
1998: Richard B Pollard; P Robinson; K Dransfield
Safety profile of nevirapine, a nonnucleoside reverse transcriptase inhibitor for the treatment of human immunodeficiency virus infection.
Clinical therapeutics 1998;20(6):1071-92.
1998: Makiko Kobayashi; Hiroyuki Kobayashi; Richard B Pollard; Fujio Suzuki
A pathogenic role of Th2 cells and their cytokine products on the pulmonary metastasis of murine B16 melanoma.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(12):5869-73.
1998: Makiko Kobayashi; Hiroyuki Kobayashi; K Mori; Richard B Pollard; Fujio Suzuki
The regulation of burn-associated infections with herpes simplex virus type 1 or Candida albicans by a non-toxic aconitine-hydrolysate, benzoylmesaconine. Part 2: Mechanism of the antiviral action.
Immunology and cell biology 1998;76(3):209-16.
1998: Makiko Kobayashi; K Mori; Hiroyuki Kobayashi; Richard B Pollard; Fujio Suzuki
The regulation of burn-associated infections with herpes simplex virus type 1 or Candida albicans by a non-toxic aconitine-hydrolysate, benzoylmesaconine. Part 1: Antiviral and anti-fungal activities in thermally injured mice.
Immunology and cell biology 1998;76(3):202-8.
1998: Makiko Kobayashi; H Kobayashi; David N Herndon; Richard B Pollard; Fujio Suzuki
Burn-associated Candida albicans infection caused by CD30+ type 2 T cells.
Journal of leukocyte biology 1998;63(6):723-31.
1998: P J Cimoch; J Lavelle; Richard B Pollard; KG Griffy; R Wong; T L Tarnowski; S Casserella; D Jung
Pharmacokinetics of oral ganciclovir alone and in combination with zidovudine, didanosine, and probenecid in HIV-infected subjects.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1998;17(3):227-34.
1998: Todd C Pappas; S Alagarsamy; Richard B Pollard; Mostafa Nokta
HIV decreases glutamate transport in SK-N-MC neuroblastoma cells.
Journal of neurovirology 1998;4(1):69-79.
1998: Judith E Feinberg; S Hurwitz; D Cooper; Fred R Sattler; Rob Roy MacGregor; W Powderly; G N Holland; Paul D Griffiths; Richard B Pollard; M Youle; M J Gill; Fiona Holland; M E Power; S Owens; D Coakley; J Fry; Mark A Jacobson
A randomized, double-blind trial of valaciclovir prophylaxis for cytomegalovirus disease in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study Group.
The Journal of infectious diseases 1998;177(1):48-56.
1997: Mostafa Nokta; R Rossero; Kim Loesch; Richard B Pollard
Kinetics of tumor necrosis factor alpha and soluble TNFRII in HIV-infected patients treated with a triple combination of stavudine, didanosine, and hydroxyurea.
AIDS research and human retroviruses 1997;13(18):1633-8.
1997: David H Shepp; C Ramirez-Ronda; L Dall; Richard B Pollard; R L Murphy; H Kessler; R Sherer; G Mertz; G Perez; D J Gocke; S B Greenberg; E Petersen; I Frank; M D Moore; R McKinnis; James F Rooney
A comparative trial of zidovudine administered every four versus every twelve hours for the treatment of advanced HIV disease.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1997;15(4):283-8.
1997: Mostafa Nokta; S G Hausrath; Richard B Pollard
Emerging treatments for viral retinitis.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 1997;7(6):423-32.
1997: Tokuichiro Utsunomiya; Makiko Kobayashi; David N Herndon; Richard B Pollard; Fujio Suzuki
A relationship between the generation of burn-associated type 2 T cells and their antagonistic cells in thermally injured mice.
Burns : journal of the International Society for Burn Injuries 1997;23(4):281-7.
1997: Mark A Jacobson; Michael E Zegans; P R Pavan; JJ O'Donnell; Fred R Sattler; N Rao; Susan Owens; Richard B Pollard
Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
Lancet 1997;349(9063):1443-5.
1997: R Matsuo; David N Herndon; Makiko Kobayashi; Richard B Pollard; Fujio Suzuki
CD4- CD8- TCR alpha/beta+ suppressor T cells demonstrated in mice 1 day after thermal injury.
The Journal of trauma 1997;42(4):635-40.
1997: Fujio Suzuki; Makiko Kobayashi; Y Komatsu; A Kato; Richard B Pollard
Keishi-ka-kei-to, a traditional Chinese herbal medicine, inhibits pulmonary metastasis of B16 melanoma.
Anticancer research 1997;17(2A):873-8.
1997: Tokuichiro Utsunomiya; Makiko Kobayashi; Richard B Pollard; Fujio Suzuki
Glycyrrhizin, an active component of licorice roots, reduces morbidity and mortality of mice infected with lethal doses of influenza virus.
Antimicrobial agents and chemotherapy 1997;41(3):551-6.
1997: Makiko Kobayashi; Richard B Pollard; Fujio Suzuki
Inhibition of pulmonary metastasis by Z-100, an immunomodulatory lipid-arabinomannan extracted from Mycobacterium tuberculosis, in mice inoculated with B16 melanoma.
Anti-cancer drugs 1997;8(2):156-63.
1996: N Nakajima; Tokuichiro Utsunomiya; M Kobayashi; David N Herndon; Richard B Pollard; Fujio Suzuki
In vitro induction of anti-type 2 T cells by glycyrrhizin.
Burns : journal of the International Society for Burn Injuries 1996;22(8):612-7.
1996: AJ Japour; J J Lertora; PM Meehan; Alejo Erice; J D Connor; B P Griffith; P A Clax; J Holden-Wiltse; S Hussey; M Walesky; E Cooney; Richard B Pollard; J Timpone; C McLaren; N Johanneson; K Wood; D Booth; Y Bassiakos; Clyde S Crumpacker
A phase-I study of the safety, pharmacokinetics, and antiviral activity of combination didanosine and ribavirin in patients with HIV-1 disease. AIDS Clinical Trials Group 231 Protocol Team.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1996;13(3):235-46.
1996: M P Busch; A Collier; Terry Gernsheimer; J D Carrington; T P Flanigan; M Kashkari; M Kennedy; P N Kumar; T A Lane; J W Mellors; Kala Mohandas; Richard B Pollard; M Viele; R Yomtovian; P V Holland; P R McCurdy
The Viral Activation Transfusion Study (VATS): rationale, objectives, and design overview.
Transfusion 1996;36(10):854-9.
1996: Mostafa Nokta; M I Hassan; K Loesch; Richard B Pollard
Human cytomegalovirus-induced immunosuppression. Relationship to tumor necrosis factor-dependent release of arachidonic acid and prostaglandin E2 in human monocytes.
The Journal of clinical investigation 1996;97(11):2635-41.
1996: R Matsuo; M Kobayashi; David N Herndon; Richard B Pollard; Fujio Suzuki
Interleukin-12 protects thermally injured mice from herpes simplex virus type 1 infection.
Journal of leukocyte biology 1996;59(5):623-30.
1996: K Ikemoto; M Kobayashi; Tetsuo Fukumoto; Mitsunori Morimatsu; Richard B Pollard; F Suzuki
2-Carboxyethylgermanium sesquioxide, a synthetic organogermanium compound, as an inducer of contrasuppressor T cells.
Experientia 1996;52(2):159-66.
1996: P K Sharkey; John Graybill; E S Johnson; S G Hausrath; Richard B Pollard; A Kolokathis; Donna Mildvan; P Fan-Havard; R H Eng; Thomas Patterson; J C Pottage; M S Simberkoff; J Wolf; R D Meyer; R Gupta; L W Lee; D S Gordon
Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1996;22(2):315-21.
1996: D P Paar; Richard B Pollard
Immunotherapy of CMV infections.
Advances in experimental medicine and biology 1996;394():145-51.
1996: Richard B Pollard
D4T nucleoside combinations for HIV.
Antiviral research 1996;29(1):101-4.
1996: Richard B Pollard
CMV retinitis: ganciclovir/monoclonal antibody.
Antiviral research 1996;29(1):73-5.
1995: David L DeMets; T R Fleming; R J Whitley; J F Childress; S S Ellenberg; M Foulkes; K H Mayer; J O'Fallon; Richard B Pollard; J J Rahal
The data and safety monitoring board and acquired immune deficiency syndrome (AIDS) clinical trials.
Controlled clinical trials 1995;16(6):408-21.
1995: M Kobayashi; David N Herndon; Richard B Pollard; Fujio Suzuki
CD4+ contrasuppressor T cells improve the resistance of thermally injured mice infected with HSV.
Journal of leukocyte biology 1995;58(2):159-67.
1995: K Ikemoto; Richard B Pollard; Tetsuo Fukumoto; Mitsunori Morimatsu; F Suzuki
Small amounts of exogenous IL-4 increase the severity of encephalitis induced in mice by the intranasal infection of herpes simplex virus type 1.
Journal of immunology (Baltimore, Md. : 1950) 1995;155(3):1326-33.
1995: Richard B Pollard; M Onorato
An approach to antiretroviral treatment of HIV disease. New approaches.
Hospital practice (1995) 1995;30 Suppl 1():32-40.
1995: K Ikemoto; Richard B Pollard; Tetsuo Fukumoto; Mitsunori Morimatsu; F Suzuki
CD8+ type-2 T cells enhance the severity of acute herpes virus infection in mice.
Immunology letters 1995;47(1-2):63-72.
1995: Mostafa Nokta; M I Hassan; K A Loesch; Richard B Pollard
HIV-induced TNF-alpha regulates arachidonic acid and PGE2 release from HIV-infected mononuclear phagocytes.
Virology 1995;208(2):590-600.
1995: Richard D Muma; M W Ross; G S Parcel; Richard B Pollard
Zidovudine adherence among individuals with HIV infection.
AIDS care 1995;7(4):439-47.
1995: Tokuichiro Utsunomiya; M Kobayashi; David N Herndon; Richard B Pollard; Fujio Suzuki
Glycyrrhizin (20 beta-carboxy-11-oxo-30-norolean-12-en-3 beta-yl-2-O-beta-D-glucopyranuronosyl-alpha-D-glucopyranosiduronic acid) improves the resistance of thermally injured mice to opportunistic infection of herpes simplex virus type 1.
Immunology letters 1995;44(1):59-66.
1994: Mostafa Nokta; M I Hassan; J A Morgan; K A Loesch; Richard B Pollard
Protein kinase C and intracellular free Ca++: relationship to human immunodeficiency virus (HIV)-induced cellular hyporesponsiveness.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1994;207(3):284-91.
1994: Richard B Pollard
Use of proteinase inhibitors in clinical practice.
Pharmacotherapy 1994;14(6 Pt 2):21S-29S.
1994: R Matsuo; M A Ball; M Kobayashi; David N Herndon; Richard B Pollard; Fujio Suzuki
Effects of a traditional Chinese herbal medicine, Kanzo-bushi-to, on the resistance of thermally injured mice infected with herpes simplex virus type 1.
International journal of immunopharmacology 1994;16(10):855-63.
1994: M A Ball; Tokuichiro Utsunomiya; K Ikemoto; M Kobayashi; Richard B Pollard; Fujio Suzuki
The antiviral effect of keishi-ni-eppi-ichi-to, a traditional Chinese herbal medicine, on influenza A2(H2N2) virus infection in mice.
Experientia 1994;50(8):774-9.
1994: M Kobayashi; David N Herndon; Richard B Pollard; Fujio Suzuki
Z-100, a lipid-arabinomannan extracted from Mycobacterium tuberculosis, improves the resistance of thermally injured mice to herpes virus infections.
Immunology letters 1994;40(3):199-205.
1994: K Ikemoto; Tokuichiro Utsunomiya; M A Ball; M Kobayashi; Richard B Pollard; Fujio Suzuki
Protective effect of shigyaku-to, a traditional Chinese herbal medicine, on the infection of herpes simplex virus type 1 (HSV-1) in mice.
Experientia 1994;50(5):456-60.
1994: Mostafa Nokta; M D Tolpin; P I Nadler; Richard B Pollard
Human monoclonal anti-cytomegalovirus (CMV) antibody (MSL 109): enhancement of in vitro foscarnet- and ganciclovir-induced inhibition of CMV replication.
Antiviral research 1994;24(1):17-26.
1994: M Kobayashi; Tokuichiro Utsunomiya; David N Herndon; Richard B Pollard; Fujio Suzuki
Effect of a traditional Chinese herbal medicine, kanzo-bushi-to, on the production of interleukin-4 from a clone of burn-associated CD8+ suppressor T cells.
Immunology letters 1994;40(1):13-20.
1994: V N Niebuhr; J R Hughes; Richard B Pollard
Parents with human immunodeficiency virus infection: perceptions of their children's emotional needs.
Pediatrics 1994;93(3):421-6.
1994: Spotswood L Spruance; Andrew T Pavia; D Peterson; A Berry; Richard B Pollard; Thomas Patterson; I Frank; S C Remick; M Thompson; Rodger D MacArthur; G E Morey; C H Ramirez-Ronda; B M Bernstein; D E Sweet; Lawrence R Crane; E A Peterson; C T Pachucki; S L Green; J Brand; A Rios; LM Dunkle; Anne Cross; M J Brown; P Ingraham; R Gugliotti; A H Schindzielorz; L Smaldone
Didanosine compared with continuation of zidovudine in HIV-infected patients with signs of clinical deterioration while receiving zidovudine. A randomized, double-blind clinical trial. The Bristol-Myers Squibb AI454-010 Study Group.
Annals of internal medicine 1994;120(5):360-8.
1994: M I Hassan; Mostafa Nokta; Richard B Pollard
Cytomegalovirus DNA polymerase activity and an 80 kDa-associated polypeptide: a potential diagnostic tool for CMV disease.
Journal of virological methods 1994;46(2):207-22.
1993: M I Hassan; Mostafa Nokta; Richard B Pollard
Involvement of cAMP and protein kinase C in cytomegalovirus enhancement of human immunodeficiency virus replication.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1993;204(2):216-23.
1993: Stephen A Spector; T Weingeist; Richard B Pollard; DT Dieterich; T Samo; Constance A Benson; D F Busch; William R Freeman; P Montague; H J Kaplan
A randomized, controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS. AIDS Clinical Trials Group and Cytomegalovirus Cooperative Study Group.
The Journal of infectious diseases 1993;168(3):557-63.
1993: Mostafa Nokta; Thomas Albrecht; Richard B Pollard
Papaverine hydrochloride: effects on HIV replication and T-lymphocyte cell function.
Immunopharmacology 1993;26(2):181-5.
1993: M Kobayashi; D A Schmitt; Tokuichiro Utsunomiya; Richard B Pollard; Fujio Suzuki
Inhibition of burn-associated suppressor cell generation by glycyrrhizin through the induction of contrasuppressor T cells.
Immunology and cell biology 1993;71 ( Pt 3)():181-9.
1993: H Sasaki; D A Schmitt; M Kobayashi; Y Hayashi; Richard B Pollard; Fujio Suzuki
Prolongation of concomitant antitumor immunity in mice treated with Z-100, an arabinomannan extracted from Mycobacterium tuberculosis.
Natural immunity 1993;12(3):152-64.
1993: J C Cozart; S S Kalangi; M H Clench; D R Taylor; MJ Borucki; Richard B Pollard; R D Soloway
Clostridium difficile diarrhea in patients with AIDS versus non-AIDS controls. Methods of treatment and clinical response to treatment.
Journal of clinical gastroenterology 1993;16(3):192-4.
1993: H Sasaki; D Schmitt; Y Hayashi; Richard B Pollard; Fujio Suzuki
Antitumor mechanisms of Z-100, an immunomodulatory arabinomannan extracted from Mycobacterium tuberculosis: the importance of lymphocytes infiltrated into tumor sites.
Natural immunity 1993;12(2):104-12.
1993: H Sasaki; D A Schmitt; K Matsumoto; Richard B Pollard; Fujio Suzuki
Demonstrations of a B-cell population that regulates the immune response in spleens of mice infected with herpes simplex virus type I.
Clinical immunology and immunopathology 1993;66(2):169-75.
1993: Fujio Suzuki; K Matsumoto; D A Schmitt; Richard B Pollard; H Maeda
Immunomodulating activities of orally administered SMANCS, a polymer-conjugated derivative of the proteinaceous antibiotic neocarzinostatin, in an oily formulation.
International journal of immunopharmacology 1993;15(2):175-83.
1992: Fujio Suzuki; D A Schmitt; Tokuichiro Utsunomiya; Richard B Pollard
Stimulation of host resistance against tumors by glycyrrhizin, an active component of licorice roots.
In vivo (Athens, Greece) 1992;6(6):589-96.
1992: D A Schmitt; K Kisanuki; S Kimura; K Oka; Richard B Pollard; H Maeda; Fujio Suzuki
Antitumor activity of orally administered SMANCS, a polymer-conjugated protein drug, in mice bearing various murine tumors.
Anticancer research 1992;12(6B):2219-24.
1992: D A Schmitt; H Sasaki; Richard B Pollard; Fujio Suzuki
Antiviral effects of recombinant human tumor necrosis factor-alpha in combination with natural interferon-beta in mice infected with herpes simplex virus type 1.
Antiviral research 1992;19(4):347-52.
1992: H Sasaki; Richard B Pollard; D Schmitt; Fujio Suzuki
Transforming growth factor-beta in the regulation of the immune response.
Clinical immunology and immunopathology 1992;65(1):1-9.
1992: Mostafa Nokta; Richard B Pollard
Human immunodeficiency virus replication: modulation by cellular levels of cAMP.
AIDS research and human retroviruses 1992;8(7):1255-61.
1992: Mostafa Nokta; J Belli; Richard B Pollard
X-irradiation enhances in vitro human immunodeficiency virus replication correlation with cellular levels of cAMP.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1992;200(3):402-8.
1992: H Sasaki; D A Schmitt; Y Hayashi; Richard B Pollard; Fujio Suzuki
Inhibition of tumor growth by the intralesional administration of interleukin-3 into mice implanted with solid tumors.
Anticancer research 1992;12(2):313-5.
1992: Richard J Whitley; John W Gnann; D Hinthorn; C Liu; Richard B Pollard; F Hayden; Gregory J Mertz; M Oxman; Seng-Jaw Soong
Disseminated herpes zoster in the immunocompromised host: a comparative trial of acyclovir and vidarabine. The NIAID Collaborative Antiviral Study Group.
The Journal of infectious diseases 1992;165(3):450-5.
1992: Richard B Pollard
Analysis and perspective from the infectious disease department.
Archives of otolaryngology--head & neck surgery 1992;118(1):19-20.
1992: H Kobayashi; H Aso; N Ishida; H Maeda; D A Schmitt; Richard B Pollard; F Suzuki
Preventive effect of a synthetic immunomodulator, 2-carboxyethylgermanium sesquioxide, on the generation of suppressor macrophages in mice immunized with allogeneic lymphocytes.
Immunopharmacology and immunotoxicology 1992;14(4):841-64.
1991: H M Shafik; Mostafa Nokta; Richard B Pollard
Recombinant human interferon beta ser protects against zidovudine-induced genetic damage in AIDS patients.
Antiviral research 1991;16(2):205-12.
1991: Mostafa Nokta; J P Loh; S M Douidar; A E Ahmed; Richard B Pollard
Metabolic interaction of recombinant interferon-beta and zidovudine in AIDS patients.
Journal of interferon research 1991;11(3):159-64.
1991: Mostafa Nokta; D Matzke; M Jennings; E Schlick; P I Nadler; Richard B Pollard
In vivo administration of tumor necrosis factor-alpha is associated with antiviral activity in human peripheral mononuclear cells.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1991;197(2):144-9.
1991: A E Ahmed; S Jacob; J P Loh; Satwant K Samra; Mostafa Nokta; Richard B Pollard
Comparative disposition and whole-body autoradiographic distribution of [2-14C]azidothymidine and [2-14C]thymidine in mice.
The Journal of pharmacology and experimental therapeutics 1991;257(1):479-86.
1991: Mostafa Nokta; Richard B Pollard
Human immunodeficiency virus infection: association with altered intracellular levels of cAMP and cGMP in MT-4 cells.
Virology 1991;181(1):211-7.
1990: H Sasaki; D Schmitt; Y Hayashi; Richard B Pollard; Fujio Suzuki
Induction of interleukin 3 and tumor resistance by SSM, a cancer immunotherapeutic agent extracted from Mycobacterium tuberculosis.
Cancer research 1990;50(13):4032-7.
1990: H Kobayashi; H Aso; N Ishida; H Maeda; Richard B Pollard; F Suzuki
Depletion of macrophages expressing I-J antigen results in efficient generation of alloreactive cytotoxic T lymphocytes.
Cellular immunology 1990;128(2):589-602.
1990: F Suzuki; Richard B Pollard; S Uchimura; T Munakata; Hiroshi Maeda
Role of natural killer cells and macrophages in the nonspecific resistance to tumors in mice stimulated with SMANCS, a polymer-conjugated derivative of neocarzinostatin.
Cancer research 1990;50(13):3897-904.
1990: Mostafa Nokta; Richard B Pollard
Patterns of interferon-gamma production by peripheral blood mononuclear cells from patients with human immunodeficiency virus infection.
Journal of interferon research 1990;10(2):173-81.
1990: Richard B Pollard; D A Schmitt; H Sasaki; Y Hayashi; Fujio Suzuki
Release of a mitogenic factor by splenic Lyt 1+ T-cells from mice treated with SSM, an immunomodulator extracted from human type tubercle bacilli.
Anticancer research 1990;10(2A):285-90.
1990: Harvey S Levin; D H Williams; MJ Borucki; G R Hillman; J B Williams; F C Guinto; E G Amparo; Wayne Crow; Richard B Pollard
Magnetic resonance imaging and neuropsychological findings in human immunodeficiency virus infection.
Journal of acquired immune deficiency syndromes 1990;3(8):757-62.
1989: Mostafa Nokta; Richard B Pollard
Differential reconstitution of zidovudine-induced inhibition of mitogenic responses by interleukin-2 in peripheral blood mononuclear cells from patients with human immunodeficiency virus infection.
Antiviral research 1989;11(4):191-202.
1989: F Suzuki; Richard B Pollard; Hiroshi Maeda
Stimulation of non-specific resistance to tumors in the mouse using a poly(maleic-acid-styrene)-conjugated neocarzinostatin.
Cancer immunology, immunotherapy : CII 1989;30(2):97-104.
1988: T Yamaguchi; Y Shinagawa; Richard B Pollard
Relationship between the production of murine cytomegalovirus and interferon in macrophages.
The Journal of general virology 1988;69 ( Pt 12)():2961-71.
1988: Fujio Suzuki; Richard B Pollard
Suppressor Lyt 2+ T-cells demonstrated in mice late after thermal injury.
Immunology letters 1988;19(1):33-9.
1988: MJ Borucki; D S Matzke; Richard B Pollard
Tremor induced by trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome (AIDS).
Annals of internal medicine 1988;109(1):77-8.
1988: Richard B Pollard
Cytomegalovirus infections in renal, heart, heart-lung and liver transplantation.
The Pediatric infectious disease journal 1988;7(5 Suppl):S97-102.
1987: G D Boyd; J M Shabot; Richard B Pollard; WK Gourley
Endoscopic evolution of gastric Kaposi's sarcoma.
Gastrointestinal endoscopy 1987;33(6):450-3.
1987: F Suzuki; Richard B Pollard
Suppressor cells generated in mice late after thermal injury.
The Journal of trauma 1987;27(4):379-83.
1986: F Suzuki; R R Brutkiewicz; Richard B Pollard
Importance of Lyt 1+ T-cells in the antitumor activity of an immunomodulator, SSM, extracted from human-type Tubercle bacilli.
Journal of the National Cancer Institute 1986;77(2):441-7.
1986: R B Lewis; D S Matzke; T B Albrecht; Richard B Pollard
Assessment of the presence of cytomegalovirus-neutralizing antibody by a plaque-reduction assay.
Reviews of infectious diseases 1986;8 Suppl 4():S434-8.
1986: F Suzuki; R R Brutkiewicz; Richard B Pollard
Lack of correlation between antitumour response and serum interferon levels in mice treated with SSM, an immunotherapeutic anticancer agent.
British journal of cancer 1986;53(4):567-70.
1986: F Suzuki; H Maeda; Richard B Pollard
Suppression of interferon gamma production in mice treated with carrageenan.
European journal of immunology 1986;16(4):375-80.
1986: F Suzuki; R R Brutkiewicz; Richard B Pollard
Cooperation of lymphokine(s) and macrophages in expression of antitumor activity of carboxyethylgermanium sesquioxide (Ge-132).
Anticancer research 1986;6(2):177-82.
1985: F Suzuki; R R Brutkiewicz; Richard B Pollard
Ability of sera from mice treated with Ge-132, an organic germanium compound, to inhibit experimental murine ascites tumours.
British journal of cancer 1985;52(5):757-63.
1985: F Suzuki; R R Brutkiewicz; Richard B Pollard
Importance of T-cells and macrophages in the antitumor activity of carboxyethylgermanium sesquioxide (Ge-132).
Anticancer research 1985;5(5):479-83.
1985: V M Howie; Richard B Pollard; S Baron
Presence of interferon during bacterial otitis media.
The Journal of infectious diseases 1985;152(2):428-9.
1984: F Suzuki; Richard B Pollard
Prevention of suppressed interferon gamma production in thermally injured mice by administration of a novel organogermanium compound, Ge-132.
Journal of interferon research 1984;4(2):223-33.
1982: Richard B Pollard; A M Arvin; P Gamberg; K H Rand; J G Gallagher; T C Merigan
Specific cell-mediated immunity and infections with herpes viruses in cardiac transplant recipients.
The American journal of medicine 1982;73(5):679-87.
1982: F Suzuki; Richard B Pollard
Mechanism for the suppression of gamma-interferon responsiveness in mice after thermal injury.
Journal of immunology (Baltimore, Md. : 1950) 1982;129(5):1811-5.
1982: F Suzuki; Richard B Pollard
Alterations of interferon production in a mouse model of thermal injury.
Journal of immunology (Baltimore, Md. : 1950) 1982;129(5):1806-10.
1982: D J Winston; Richard B Pollard; W G Ho; J G Gallagher; L E Rasmussen; S N Huang; C H Lin; T G Gossett; T C Merigan; R P Gale
Cytomegalovirus immune plasma in bone marrow transplant recipients.
Annals of internal medicine 1982;97(1):11-8.
1982: V Howie; Richard B Pollard; K Kleyn; B Lawrence; T Peskuric; K Paucker; S Baron
Presence of interferon during bacterial otitis media.
The Journal of infectious diseases 1982;145(6):811-4.
1982: S L Sacks; G H Scullard; Richard B Pollard; P B Gregory; W S Robinson; T C Merigan
Antiviral treatment of chronic hepatitis B virus infection: pharmacokinetics and side effects of interferon and adenine arabinoside alone and in combination.
Antimicrobial agents and chemotherapy 1982;21(1):93-100.
1981: K C Hyams; J T Mader; Richard B Pollard; D H Parks; P D Thomson; J A Reinarz
Serratia endocarditis in a pediatric burn patient. Cure with cefotaxime.
JAMA : the journal of the American Medical Association 1981;246(9):983-4.
1981: G H Scullard; Richard B Pollard; J L Smith; S L Sacks; P B Gregory; W S Robinson; T C Merigan
Antiviral treatment of chronic hepatitis B virus infection. I. Changes in viral markers with interferon combined with adenine arabinoside.
The Journal of infectious diseases 1981;143(6):772-83.
1981: T C Merigan; J G Gallagher; Richard B Pollard; A M Arvin
Short-course human leukocyte interferon in treatment of herpes zoster in patients with cancer.
Antimicrobial agents and chemotherapy 1981;19(1):193-5.
1980: P R Egbert; Richard B Pollard; J G Gallagher; T C Merigan
Cytomegalovirus retinitis in immunosuppressed hosts. II. Ocular manifestations.
Annals of internal medicine 1980;93(5):664-70.
1980: Richard B Pollard; P R Egbert; J G Gallagher; T C Merigan
Cytomegalovirus retinitis in immunosuppressed hosts. I. Natural history and effects of treatment with adenine arabinoside.
Annals of internal medicine 1980;93(5):655-64.
1980: A M Arvin; Richard B Pollard; L E Rasmussen; T C Merigan
Cellular and humoral immunity in the pathogenesis of recurrent herpes viral infections in patients with lymphoma.
The Journal of clinical investigation 1980;65(4):869-78.
1979: Barry Hafkin; Richard B Pollard; M L Tiku; W S Robinson; T C Merigan
Effects of interferon and adenine arabinoside treatment of hepatitis B virus infection on cellular immune responses.
Antimicrobial agents and chemotherapy 1979;16(6):781-7.
1979: S L Sacks; J L Smith; Richard B Pollard; V Sawhney; A S Mahol; P Gregory; T C Merigan; W S Robinson
Toxicity of vidarabine.
JAMA : the journal of the American Medical Association 1979;241(1):28-9.
1978: Richard B Pollard; K H Rand; A M Arvin; T C Merigan
Cell-mediated immunity of cytomegalovirus infection in normal subjects and cardiac transplant patients.
The Journal of infectious diseases 1978;137(5):541-9.
1978: A M Arvin; Richard B Pollard; L E Rasmussen; T C Merigan
Selective impairment of lymphocyte reactivity to varicella-zoster virus antigen among untreated patients with lymphoma.
The Journal of infectious diseases 1978;137(5):531-40.
1978: K H Rand; Richard B Pollard; T C Merigan
Increased pulmonary superinfections in cardiac-transplant patients undergoing primary cytomegalovirus infection.
The New England journal of medicine 1978;298(17):951-3.
1978: Richard B Pollard; J L Smith; A Neal; P B Gregory; T C Merigan; W S Robinson
Effect of vidarabine on chronic hepatitis B virus infection.
JAMA : the journal of the American Medical Association 1978;239(16):1648-50.
1978: Richard B Pollard; T C Merigan
Perspectives for the control of cytomegalovirus infections in bone marrow transplant recipients.
Transplantation proceedings 1978;10(1):241-5.
1978: A M Arvin; Richard B Pollard; L E Rasmussen; K H Rand; T C Merigan
Lymphocyte transformation and interferon production as measures of cellular immunity in lymphoma patients.
IARC scientific publications 1978;(24 Pt 2):745-51.
1977: K H Rand; L E Rasmussen; Richard B Pollard; A Arvin; T C Merigan
Cellular immunity and herpesvirus infections in cardiac-transplant patients.
The New England journal of medicine 1977;296(24):1372-7.
1976: Harry B Greenberg; Richard B Pollard; L I Lutwick; P B Gregory; W S Robinson; T C Merigan
Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis.
The New England journal of medicine 1976;295(10):517-22.